Treace Medical Concepts Inc (TMCI)
7.94
-0.04
(-0.50%)
USD |
NASDAQ |
Nov 21, 16:00
7.95
+0.01
(+0.13%)
After-Hours: 20:00
Treace Medical Concepts Enterprise Value: 465.07M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 465.07M |
| November 20, 2024 | 467.56M |
| November 19, 2024 | 453.86M |
| November 18, 2024 | 429.56M |
| November 15, 2024 | 444.51M |
| November 14, 2024 | 445.76M |
| November 13, 2024 | 463.82M |
| November 12, 2024 | 471.30M |
| November 11, 2024 | 486.88M |
| November 08, 2024 | 471.30M |
| November 07, 2024 | 462.58M |
| November 06, 2024 | 455.10M |
| November 05, 2024 | 329.26M |
| November 04, 2024 | 308.71M |
| November 01, 2024 | 268.21M |
| October 31, 2024 | 260.74M |
| October 30, 2024 | 268.73M |
| October 29, 2024 | 270.60M |
| October 28, 2024 | 271.84M |
| October 25, 2024 | 262.50M |
| October 24, 2024 | 277.45M |
| October 23, 2024 | 286.79M |
| October 22, 2024 | 301.11M |
| October 21, 2024 | 304.23M |
| October 18, 2024 | 302.98M |
| Date | Value |
|---|---|
| October 17, 2024 | 299.87M |
| October 16, 2024 | 304.85M |
| October 15, 2024 | 301.74M |
| October 14, 2024 | 294.26M |
| October 11, 2024 | 298.00M |
| October 10, 2024 | 286.79M |
| October 09, 2024 | 296.13M |
| October 08, 2024 | 293.02M |
| October 07, 2024 | 296.76M |
| October 04, 2024 | 302.98M |
| October 03, 2024 | 299.25M |
| October 02, 2024 | 309.83M |
| October 01, 2024 | 307.34M |
| September 30, 2024 | 331.63M |
| September 27, 2024 | 316.95M |
| September 26, 2024 | 318.82M |
| September 25, 2024 | 290.21M |
| September 24, 2024 | 295.80M |
| September 23, 2024 | 287.10M |
| September 20, 2024 | 296.43M |
| September 19, 2024 | 306.38M |
| September 18, 2024 | 298.91M |
| September 17, 2024 | 282.12M |
| September 16, 2024 | 269.68M |
| September 13, 2024 | 276.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
201.65M
Minimum
May 08 2024
1.926B
Maximum
Jun 11 2021
967.10M
Average
980.98M
Median
Enterprise Value Benchmarks
| Stryker Corp | 159.53B |
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.36M |
| Revenue (Quarterly) | 45.09M |
| Total Expenses (Quarterly) | 60.22M |
| EPS Diluted (Quarterly) | -0.25 |
| Gross Profit Margin (Quarterly) | 80.14% |
| Profit Margin (Quarterly) | -34.07% |
| Earnings Yield | -12.50% |
| Normalized Earnings Yield | -12.50 |